Alopecia in women; Baldness - female; Hair loss in women; Androgenic alopecia in women
The hair loss of female pattern baldness is permanent. In most cases, it is mild to moderate. No treatment is required if the person is comfortable with her appearance.
The only drug or medication approved by the United States Food and Drug Administration (FDA) to treat female pattern baldness is minoxidil, used on the scalp. For women, the 2% concentration is recommended. Minoxidil may help hair to grow in 20% to 25% of the female population, and in the majority it may slow or stop the loss of hair. Treatment is expensive, however, and hair loss starts again when minoxidil use is stopped.
Hair transplants consist of removal of tiny plugs of hair from areas where the hair is continuing to grow and placing them in areas that are balding. This can cause minor scarring in the donor areas and carries a modest risk for skin infection. The procedure usually requires multiple transplantation sessions and may be expensive. Results, however, are often excellent and permanent.
The use of hair implants made of artificial fibers was banned by the FDA because of the high rate of infection.
Stitching (suturing) hair pieces to the scalp is not recommended. It can result in scars, infections, and abscess of the scalp.
Hair weaving, hairpieces, or change of hairstyle may disguise hair loss and improve cosmetic appearance. This is often the least expensive and safest method of dealing with female pattern baldness.
Female pattern baldness is of cosmetic importance only and does not indicate a medical disorder, but it may affect self-esteem or cause anxiety. The hair loss is usually permanent.
Complications are psychological stress and a loss of self-esteem due to change in appearance.
Habif TP. Clinical Dermatology. 4th ed. St. Louis, Mo: Mosby, Inc. 2004:844.
Cummings CW, Flint PW, Haughey BH, et al. Otolaryngology: Head & Neck Surgery. 4th ed. St Louis, Mo; Mosby; 2005:677-679.